Black Rock Petroleum Co issued an update identifying Lotus Bio-Technology Development Corp. as the company in question. For investors, the update says allegations have not been proven in court and that earlier filings dating back to August 2022 may or may not have included the disclosure.
Key Highlights
- The update carries a September 16, 2026 date.
- Zoltan Nagy signed the report as President, Chief Executive Officer and Treasurer.
- The report cites requirements under the Securities Exchange Act of 1934.
Black Rock Petroleum Co (OTC: BKRP) issued an update identifying Lotus Bio-Technology Development Corp. as the company in question.
September 16 Update Names Lotus Bio-Technology
The update is dated September 16, 2026. Black Rock Petroleum Company signed it through Zoltan Nagy, whose stated roles are President, Chief Executive Officer and Treasurer. The signature states that the report was executed under the requirements of the Securities Exchange Act of 1934. Nagy signed on behalf of the company.
FAQs
Q: What did Black Rock Petroleum say about Lotus Bio-Technology Development Corp.?
A: Black Rock Petroleum’s September 16, 2026 update identified Lotus Bio-Technology Development Corp. as the company in question. The update was signed on behalf of Black Rock Petroleum by Zoltan Nagy.
Q: When was Black Rock Petroleum’s company update dated?
A: The company update bears the date September 16, 2026. It was signed by Zoltan Nagy, who is identified as President, Chief Executive Officer and Treasurer.
Q: Could earlier Black Rock Petroleum filings have included the disclosure?
A: The article does not state whether earlier Black Rock Petroleum filings included the disclosure. It only identifies the September 16, 2026 update as naming Lotus Bio-Technology Development Corp.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.